Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126145941 | 12614594 | 1 | I | 20160727 | 20160802 | 20160802 | EXP | AU-JNJFOC-20160725004 | JANSSEN | 0.00 | Y | 0.00000 | 20160802 | PH | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126145941 | 12614594 | 1 | PS | INVEGA SUSTENNA | PALIPERIDONE PALMITATE | 1 | Intramuscular | N | 22264 | INJECTION | |||||||||
| 126145941 | 12614594 | 2 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126145941 | 12614594 | 3 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126145941 | 12614594 | 4 | C | WARFARIN | WARFARIN | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126145941 | 12614594 | 1 | Product used for unknown indication |
| 126145941 | 12614594 | 2 | Product used for unknown indication |
| 126145941 | 12614594 | 3 | Product used for unknown indication |
| 126145941 | 12614594 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126145941 | 12614594 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126145941 | 12614594 | Hospitalisation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |